Profile picture

Doctor Martin Franz Reiner

University Heart Center, Zurich (Switzerland)
Membership: ESC Professional Member EHRA Member
Follow
Biography
Martin F. Reiner, MD, PhD, is a cardiologist and specialist in internal medicine currently working at the Department of Cardiology at the University Heart Center, University Hospital Zurich (Switzerland). After graduating from medical school at the University of Innsbruck (Austria) in 2012, he completed the MD-PhD program at the Faculty of Science at the University of Zurich, followed by specialization in Internal Medicine and Cardiology at the Cantonal Hospital Baden (Switzerland) and the University Hospital Zurich. His research focuses on thrombogenesis in cardio- and cerebrovascular disease and arrhythmogenic mitral valve prolapse, with an emphasis on translational approaches to bridge basic science and clinical studies. Additionally, Dr. Reiner is a member of the European Society of Cardiology's Working Group on Cardiovascular Pharmacotherapy.
Logo ESC

Contributor content

Incidence, predictors and outcome of severe tricuspid regurgitation after transvenous lead extraction: real-world experience from a Swiss nationwide cohort study
Presentation
Incidence, predictors and outcome of severe tricuspid regurgitation after transvenous lead extraction: real-world experience from a Swiss nationwide cohort study
Functional and morphological predictors of left ventricular fibrosis in patients with mitral annular disjunction in cardiac magnetic resonance imaging
Presentation
Functional and morphological predictors of left ventricular fibrosis in patients with mitral annular disjunction in cardiac magnetic resonance imaging
Photon-counting detector computed tomography correlates with invasive electroanatomical mapping for myocardial substrate characterization in patients with structural heart disease
Presentation
Photon-counting detector computed tomography correlates with invasive electroanatomical mapping for myocardial substrate characterization in patients with structural heart disease
The omega-3 fatty acid eicosapentaenoic acid (EPA) is inversely associated with ischemic brain infarcts in elderly patients with atrial fibrillation
Presentation
The omega-3 fatty acid eicosapentaenoic acid (EPA) is inversely associated with ischemic brain infarcts in elderly patients with atrial fibrillation
Trimethylamine-N-oxide (TMAO) Predicts Total Mortality, but not Recurrent Venous Thromboembolism in Elderly Patients with Acute Venous Thromboembolism
Presentation
Trimethylamine-N-oxide (TMAO) Predicts Total Mortality, but not Recurrent Venous Thromboembolism in Elderly Patients with Acute Venous Thromboembolism
Ticagrelor, but not clopidogrel active metabolite, exerts antithrombotic properties on left atrial endocardial cells of patients with atrial fibrillation, in vitro
Presentation
Ticagrelor, but not clopidogrel active metabolite, exerts antithrombotic properties on left atrial endocardial cells of patients with atrial fibrillation, in vitro
Endothelial lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) exacerbates ischemia/reperfusion-induced cerebral injury
Presentation
Endothelial lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) exacerbates ischemia/reperfusion-induced cerebral injury

ESC 365 is supported by